| "Advances in Hepatobiliary Diseases - Clinician's
Perspective" 2-3 September 2017, Hotel Vivanta by Taj,Dwarka, New Delhi, India Organized By Institute of Liver Gastroenterology & Pancreaticobiliary Sciences (ILGPS) Sir Ganga Ram Hospital, New Delhi Under the aegis of Delhi Liver Foundation |
"Advances in Hepatobiliary Diseases - Clinician's
Perspective" 2-3 September 2017, Hotel Vivanta by Taj,Dwarka, New Delhi, India Organized By Institute of Liver Gastroenterology & Pancreaticobiliary Sciences (ILGPS) Sir Ganga Ram Hospital, New Delhi Under the aegis of Delhi Liver Foundation |
||||||||||||
| Day 1 : September 2, 2017, Saturday | Day 1 : September 2, 2017, Saturday | ||||||||||||
| HALL A | HALL B | ||||||||||||
| Timing | Duration | Session | Topics | Speakers | Timing | Session | Topics | Speakers | |||||
| 9:00 | 9:20 | 15+5 | Session 1: Portal Hypertension-A |
Topics | Dr Rajesh
Puri |
9:00 | 9:20 | 15+5 | Session 2: Portal Hypertension-B |
Plasma Exchange in Liver Failure: Rationale and Outcome | Dr Joy Varghese | ||
| 9:20 | 9:40 | 15+5 | Gastric varices: GLUE or TIPSS ? | Dr Sandeep Nijhawan | 9:20 | 9:40 | 15+5 | Early TIPSS : When and for whom ? | Dr Manav Wadhawan | ||||
| 9:40 | 10:00 | 15+5 | Carvidelol or Propranolol in compensated liver cirrhosis: Which one to choose ? | Dr Sandeep Thareja | 9:40 | 10:00 | 15+5 | Midodrine for refractory ascities | Dr Virendra Singh | ||||
| 10:00 | 10:20 | 15+5 | Non invasive predictors of clinical significant portal hypertension: how reliable are they? | Dr Bhaskar Nandi | 10:00 | 10:20 | 15+5 | Portal Biliopathy : Definition and Management | Dr Showkat Zargar | ||||
| 10:20 | 10:40 | 15+5 | Portal hypertension in pregnancy: Implication and management | Dr Harshad Devarbhavi | 10:20 | 10:40 | 15+5 | Portal enteropathy and colopathy: Management | Dr Srikant Mukewar | ||||
| 10:40 | 11:00 | 15+5 | Beta blockers in decompensated liver disease: Boon or bane? | Dr G N Ramesh | 10:40 | 11:00 | 15+5 | Role of anticoagulation in EHPVO and BCS in India | Dr Akash Shukla | ||||
| 11:00 | 11:20 | 15+5 | Emerging role of statins in Liver disease | Dr C C Chaubal | 11:00 | 11:20 | 15+5 | Anticogulation in CLD : Which, when and how ? | Dr Ajay Kumar | ||||
| 11:20 | 11:45 | 25 min | INAUGURATION followed by TEA | 11:20 | 11:45 | 25 min | INAUGURATION in HALL A | ||||||
| 11:45 | 12:15 | 30 min | Dr S K Sama Oration | Growth of Hepatology in India | Dr M S Khuroo | 11:45 | 12:15 | 30 min | Dr S K Sama Oration in HALL A | ||||
| 12:15 | 12:35 | 20 min | State of the Art Lecture 1 | Current and Emerging Therapies for Severe Alcoholic Hepatitis | Dr Shiv K Sarin | 12:15 | 12:35 | 20 min | State of the Art Lecture 1 in HALL A | Dr Shiv K Sarin | |||
| 12:35 | 12:55 | 15+5 | Session 3
: Case Discussion |
Obscure G I Bleed in patient with Cirrhosis: Approach to management | Dr Manu Tandan | 12:35 | 12:55 | 15+5 | Case Discussion in HALL A | ||||
| 12:55 | 13:15 | 15+5 | State of the Art Lecture 2 | ACLF: Why it is still looking for consensus definition ? | Dr S K Tyagi | 12:55 | 13:15 | 15+5 | State of the Art Lecture 2 in HALL A | ACLF: Why it is still looking for consensus definition ? | |||
| 13:15 | 14:00 | 45 min | Lunch Break | 13:15 | 14:00 | 45 min | Lunch Break | ||||||
| 14:00 | 14:20 | 15+5 | Session
4 : ACLF |
Leaky GUT and Liver: HOPE or HYPE ? | Dr S P Misra | 14:00 | 14:20 | 15+5 | Session 5 : Alcoholic Liver Disease | Utility of steroids for Alcoholic Hepatitis in clinical practice | Dr Manisha Dwivedi | ||
| 14:20 | 14:40 | 15+5 | Hepatic versus Non-hepatic acute insult in ACLF: Does it change prognosis ? | Dr A C Anand | 14:20 | 14:40 | 15+5 | Alcoholic Liver Disease: Why do the medical therapies consistently fail ? | Dr Sandeep Sidhu | ||||
| 14:40 | 15:00 | 15+5 | Role of antiviral in Liver failure due to hepatitis B and E | Dr Ramesh Roop Rai | 14:40 | 15:00 | 15+5 | Fecal transplantation in Liver disease: Are we overrating gut microbiome? | Dr Siva Prasad | ||||
| 15:00 | 15:20 | 15+5 | Session 6 : NAFLD |
Simple Steotosis : Natural history and management | Dr Ajay Duseja[cnf] | 15:00 | 15:20 | 15+5 | Session 7 : Hepatocellular Carcinoma |
Screening and prevention in HCC : When and how ? | Dr V K Dixit | ||
| 15:20 | 15:40 | 15+5 | NASH - New molecular targets for management | Dr Kaushal Madan | 15:20 | 15:40 | 15+5 | Hepatocellular Carcinoma mimics in chronic liver disease | Dr Samarjit Ghuman | ||||
| 15:40 | 16:00 | 15+5 | NASH : Should we look beyond Liver ? | Dr Neeraj Saraf | 15:40 | 16:00 | 15+5 | Surgery in HCC : When and for whom ? | Dr Anil Agarwal | ||||
| 16:00 | 16:20 | 15+5 | Management of obese decompensated Cirrhosis | Dr Sanjiv Saigal | 16:00 | 16:20 | 15+5 | Session 9 : Miscellaneous 2 | Covert hepatic encephalopathy : Should we screen and treat in India ? | Dr Anoop Saraya | |||
| 16:20 | 16:40 | 15+5 | Management of obesity : Does the GUT manipulation help ? | Dr Vineet Ahuja | 16:20 | 16:40 | 15+5 | Cholestatic liver disease: What a hepatologist should know ? | Dr Neelam Mohan | ||||
| 16:40 | 17:10 | 12+12+6 | DEBATE:
Bariatric surgery as a primary treatment of NASH |
FOR
: Dr Praveen Bhatia AGAINST: Dr Yogesh Batra |
16:40 | 17:00 | 15+5 | Judicious use of NSAID's and Antibiotics in Liver Disease | Dr Usha Dutta | ||||
| 17:10 | 17:30 | 15+5 | Lean NASH: Pathophysiology and management | Dr Manisha Bangar | 17:00 | 17:20 | 15+5 | Safety of newer anti-diabetic medication in cirrhosis | Dr Deepak Agarwal | ||||
| 17:30 | 17:50 | 15+5 | Session
8 : Miscellaneous 1 |
Autoimmune cholangiopathies (including IgG4 disease) | Dr R K Wadhwa | 17:20 | 17:40 | 15+5 | Hyponatremia and ascites in a patients with decompensated cirrhosis | Dr Gaurav Pandey | |||
| 17:50 | 18:10 | 15+5 | Coil Injection Therapy for Gastric varices | Dr Vikas Singla | 17:40 | 18:00 | 15+5 | Management of Chronic Porta Systemic Encephalopathy | Dr V Jayanthi | ||||
| 18:10 | 18:30 | 15+5 | Risk stratification of surgery in patient with cirrhosis | Dr B D Goswami | 18:00 | 18:20 | 15+5 | Assessment and management of Sarcopenia in cirrhosis | Dr K Narayansamy | ||||
| 20:00 | 20:30 | 30 min | Dinner Symposium in HALL B | Dr D N Reddy | 20:00 | 20:30 | 30 min | Dinner Symposium | Endoscopic Hepatobiliary Intervention : Current perspective and future strategies | Dr D N Reddy | |||
| Musical night & Gala Dinner - 8:30 PM onwards | Musical night & Gala Dinner - 8:30 PM onwards | ||||||||||||
| Day 2 : September 3, 2017, Sunday | Day 2 : September 3, 2017, Sunday | ||||||||||||
| HALL A | HALL B | ||||||||||||
| Timing | Duration | Session | Topics | Speakers | Timing | Duration | Session | Topics | Speakers | ||||
| 8:30 | 8:50 | 15+5 | Session 10 : Hepatitis B |
Future strategies to treat Hepatits B | Dr Vivek Saraswat | 8:30 | 8:50 | 15+5 | Session 11 : Hepatitis C |
DAAs in decompensated HCV related cirrhosis : Current perspective | Dr Pankaj Puri | ||
| 8:50 | 9:10 | 15+5 | Combination therapy of oral antiviral for Hepatitis B: Do they work ? | Dr S P Singh | 8:50 | 9:10 | 15+5 | How to treat DAAs treatment failure | Dr Shalimar | ||||
| 9:10 | 9:30 | 15+5 | Management of Hepatitis B in patients with CKD | Dr R K Jain | 9:10 | 9:30 | 15+5 | Genotype and RAV testing in the present DAA era: For whom and when ? | Dr Y K Chawla | ||||
| 9:30 | 9:50 | 15+5 | Relevance of HbeAg in management of Hepatitis B in India | Dr Dharmesh Kapoor | 9:30 | 9:50 | 15+5 | Core antigen estimation: can it replace costlier HCV viral load? | Dr Anil Arora | ||||
| 9:50 | 10:10 | 15+5 | Incidently detected HbsAg with raised DNA(>20000 IU/ml) and normal ALT: what next? | Dr K T Shenoy | 9:50 | 10:10 | 15+5 | DAA treatment for HCV in CKD Patient in 2018 | Dr | ||||
| 10:10 | 10:30 | 15+5 | Hepatitis B in Pregnancy : When to treat? | Dr K C Sudhamshu | 10:10 | 10:30 | 15+5 | Management of Hepatitis C: Can the Punjab model be implemented into national perspective ? | Dr R K Dhiman | ||||
| 10:30 | 10:50 | 15+5 | Immuno Therapy for Hepatitis B : From bench To bedsides | Dr S M F Akbar | 10:30 | 11:00 | 30 min | TEA | |||||
| 10:50 | 11:00 | 10 min | TEA | 11:00 | 11:20 | 20 min | State of the Art Lecture 3 in HALL A | Dr S K Acharya | |||||
| 11:00 | 11:20 | 20 min | State of the Art Lecture 3 | ALF in pregnancy : differential diagnosis and management | Dr S K Acharya | 11:20 | 11:40 | 15+5 | Session 13 : Hepatobiliary Diseases | RFA in Hepatobiliary Malignancy | Dr Mahesh Goenka | ||
| 11:20 | 11:40 | 15+5 | Session 12 : Liver Transplantation |
Liver Transplantation in Hepatobiliary Neoplasia : When and for whom ? | Dr A S Soin | 11:40 | 12:00 | 15+5 | Management of large CBD stones | Dr Randhir Sud | |||
| 11:40 | 12:00 | 15+5 | Justification of Liver Transplantation beyond the conventional criteria | Dr Subhash Gupta | 12:00 | 12:20 | 15+5 | Tissue diagnosis for Hilar masses | Dr Pramod Garg | ||||
| 12:00 | 12:20 | 15+5 | Immuno suppression in Liver Transplant | Dr B B Gul | 12:20 | 12:40 | 15+5 | Laparoscopic Biliary surgery: from Laparoscopic Cholecystectomy to laparoscopic whipple procedure | Dr Ajay K Kriplani | ||||
| 12:20 | 12:40 | 15+5 | Session 14: Miscellaneous 3 |
Hepatobiliary manifestation of IBD | Dr A S Puri | 12:40 | 13:00 | 15+5 | Liver and Celiac disease : emerging concepts | Dr Govind Makharia | |||
| 12:40 | 13:00 | 15+5 | HEV in late pregnancy : Why is it so lethal? | Dr Premashish Kar | LUNCH 13:30 PM ONWARDS POST VOTE OF THANKS | ||||||||
| 13:00 | 13:20 | 15+5 | Hilar cholangio carcinoma: dilema in management | Dr T S Chandrasekar | |||||||||
| 13:20 | 13:30 | 10 min | VOTE OF THANKS | ||||||||||
| 13:30 | 14:30 | 1 Hr | LUNCH BREAK | ||||||||||